4512 — Wakamoto Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥10bn
- ¥8bn
- ¥8bn
- 26
- 36
- 26
- 15
Annual cashflow statement for Wakamoto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -703 | 285 | 212 | 159 | 7.46 |
| Depreciation | |||||
| Non-Cash Items | -30.8 | -223 | 14.4 | -478 | -524 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 413 | -193 | -39.8 | -200 | -506 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 163 | 339 | 632 | -107 | -592 |
| Capital Expenditures | -451 | -303 | -163 | -556 | -476 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 252 | 353 | 180 | 553 | 462 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -200 | 50.6 | 17.1 | -2.35 | -13.5 |
| Financing Cash Flow Items | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.83 | -1.62 | -1.61 | -105 | -104 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -39.9 | 388 | 647 | -215 | -710 |